Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Gavreto 100 mg hard capsules {equilateral_black_triangle}

Active Ingredient:
pralsetinib
Company:  
Roche Products Limited See contact details
ATC code: 
L01EX23
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Letters to HCPs HCP Med Info
{arrow_left}
{arrow_right}

Important information for Healthcare Professionals

{pdf_link}

GAVRETO®▼(pralsetinib) Direct Healthcare Professional Communication

{healthcare_pro_orange} For Healthcare Professionals
GAVRETO®▼(pralsetinib) Direct Healthcare Professional Communication: Planned transition of Market Authorisation Holder from Roche Products Limited to BluePrint Medicines resulting in discontinuation of supply from Roche Products Limited
{pdf_link}

GAVRETO®▼(pralsetinib): Increased risk for tuberculosis and measures to minimise this risk

{healthcare_pro_orange} For Healthcare Professionals
Direct Healthcare Professional Communication for increased risk of tuberculosis and measures to minimise this risk

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Roche Products Limited
Company image
Address
Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW
Telephone
+44 (0)1707 366 000
Fax
+44 (0)1707 338 297
Medical Information Direct Line
+44 (0)800 328 1629
Customer Care direct line
+44 (0)800 731 5711
Medical Information e-mail
[email protected]
Medical Information Fax
+44 (0)1707 384555
WWW
http://www.roche.co.uk